Ellington Management Group’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-10,800
Closed -$45K 780
2019
Q3
$45K Buy
+10,800
New +$45K 0.01% 540